Cargando…
Mucosal associated Lymphoid Tissue Lymphoma of the uvea: an analysis of 3 cases
BACKGROUND: Ocular mucosa-associated lymphoid tissue (MALT) lymphoma involving orbit and conjunctiva usually has an indolent clinical course with “salmon patch” mass as typical presentation. This study is to report a series of rare cases and investigate the clinical and pathological features of ocul...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484074/ https://www.ncbi.nlm.nih.gov/pubmed/36123589 http://dx.doi.org/10.1186/s12886-022-02598-2 |
_version_ | 1784791805969039360 |
---|---|
author | Wang, Zhenyu Liu, Yueming Mo, Jing Cao, Xusheng Xu, Xiaolin Shen, Lin Wang, Hong Wei, Wenbin |
author_facet | Wang, Zhenyu Liu, Yueming Mo, Jing Cao, Xusheng Xu, Xiaolin Shen, Lin Wang, Hong Wei, Wenbin |
author_sort | Wang, Zhenyu |
collection | PubMed |
description | BACKGROUND: Ocular mucosa-associated lymphoid tissue (MALT) lymphoma involving orbit and conjunctiva usually has an indolent clinical course with “salmon patch” mass as typical presentation. This study is to report a series of rare cases and investigate the clinical and pathological features of ocular MALT lymphoma that involved uveal tissue primarily and presented as posterior scleritis. METHODS: This retrospective, observational study was conducted at Beijing Tongren Hospital. From 2018 to 2020, 3 cases of 3 eyes (2 female patients and 1 male patient) with ocular MALT lymphoma that involved uveal tissue primarily and presented as posterior scleritis were included in the study. All patients had complaints of red eyes with blurred vision. The average age was 56.33 ± 2.08 years old and the average time from initial diagnosis to pathological diagnosis was 3.00 ± 1.73 months. Ophthalmic examinations including best-corrected visual acuity (BCVA), intraocular pressure (IOP), slit lamp microscope examinations, fundus photography, B-scan ultrasonography, ultrasound biomicroscope (UBM), optical coherence tomography (OCT), fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) were conducted. Systemic workups including orbital magnetic resonance imaging (MRI), positron emission tomography-computed tomography (PET-CT) and blood autoimmune antibody tests were also conducted. Pathological tissue from patients were obtained through surgeries. Biopsy examinations were performed to accurately determine pathological diagnosis. All the information of clinical, imaging and pathological changes were collected and analyzed. RESULTS: At the initial diagnosis, the BCVA of involved eyes decreased seriously while the IOP were normal. All involved eyeball showed extensive hyperemia and local thickening in the wall of eyeballs. B-scan ultrasonography showed mass with abundant blood and irregular cysts inside the eyeball wall and in the retrobulbar orbit, surrounding the ocular wall and optic nerve. UBM showed solid lesions with low and medium echo under the conjunctiva and inside the ciliary body of 2 cases. OCT showed posterior polar wavy rise of RPE and local neuroepithelial detachment in all cases. FFA and ICGA showed vascular abnormalities (patch-like strong fluorescence and fluorescence leakage) and local thickening in retina and choroid (Rectangle-like weak fluorescence below the macula). The posterior wall of the eyeball was thickened and enhanced in MRI. PET-CT also showed thickening of posterior wall of eyeballs and increased metabolic activity but there was no sign of autoimmune disease. All patients were diagnosed as MALT lymphoma through pathologic examinations of biopsy tissue. CONCLUSIONS: The onset of primary ocular MALT lymphoma in uvea is hidden. The early clinical manifestations are lack of specificity and misleading. B-scan ultrasonography has characteristic manifestations and is valuable in diagnosis. However, pathological diagnosis through tissue biopsy is irreplaceable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12886-022-02598-2. |
format | Online Article Text |
id | pubmed-9484074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-94840742022-09-20 Mucosal associated Lymphoid Tissue Lymphoma of the uvea: an analysis of 3 cases Wang, Zhenyu Liu, Yueming Mo, Jing Cao, Xusheng Xu, Xiaolin Shen, Lin Wang, Hong Wei, Wenbin BMC Ophthalmol Research BACKGROUND: Ocular mucosa-associated lymphoid tissue (MALT) lymphoma involving orbit and conjunctiva usually has an indolent clinical course with “salmon patch” mass as typical presentation. This study is to report a series of rare cases and investigate the clinical and pathological features of ocular MALT lymphoma that involved uveal tissue primarily and presented as posterior scleritis. METHODS: This retrospective, observational study was conducted at Beijing Tongren Hospital. From 2018 to 2020, 3 cases of 3 eyes (2 female patients and 1 male patient) with ocular MALT lymphoma that involved uveal tissue primarily and presented as posterior scleritis were included in the study. All patients had complaints of red eyes with blurred vision. The average age was 56.33 ± 2.08 years old and the average time from initial diagnosis to pathological diagnosis was 3.00 ± 1.73 months. Ophthalmic examinations including best-corrected visual acuity (BCVA), intraocular pressure (IOP), slit lamp microscope examinations, fundus photography, B-scan ultrasonography, ultrasound biomicroscope (UBM), optical coherence tomography (OCT), fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) were conducted. Systemic workups including orbital magnetic resonance imaging (MRI), positron emission tomography-computed tomography (PET-CT) and blood autoimmune antibody tests were also conducted. Pathological tissue from patients were obtained through surgeries. Biopsy examinations were performed to accurately determine pathological diagnosis. All the information of clinical, imaging and pathological changes were collected and analyzed. RESULTS: At the initial diagnosis, the BCVA of involved eyes decreased seriously while the IOP were normal. All involved eyeball showed extensive hyperemia and local thickening in the wall of eyeballs. B-scan ultrasonography showed mass with abundant blood and irregular cysts inside the eyeball wall and in the retrobulbar orbit, surrounding the ocular wall and optic nerve. UBM showed solid lesions with low and medium echo under the conjunctiva and inside the ciliary body of 2 cases. OCT showed posterior polar wavy rise of RPE and local neuroepithelial detachment in all cases. FFA and ICGA showed vascular abnormalities (patch-like strong fluorescence and fluorescence leakage) and local thickening in retina and choroid (Rectangle-like weak fluorescence below the macula). The posterior wall of the eyeball was thickened and enhanced in MRI. PET-CT also showed thickening of posterior wall of eyeballs and increased metabolic activity but there was no sign of autoimmune disease. All patients were diagnosed as MALT lymphoma through pathologic examinations of biopsy tissue. CONCLUSIONS: The onset of primary ocular MALT lymphoma in uvea is hidden. The early clinical manifestations are lack of specificity and misleading. B-scan ultrasonography has characteristic manifestations and is valuable in diagnosis. However, pathological diagnosis through tissue biopsy is irreplaceable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12886-022-02598-2. BioMed Central 2022-09-19 /pmc/articles/PMC9484074/ /pubmed/36123589 http://dx.doi.org/10.1186/s12886-022-02598-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Zhenyu Liu, Yueming Mo, Jing Cao, Xusheng Xu, Xiaolin Shen, Lin Wang, Hong Wei, Wenbin Mucosal associated Lymphoid Tissue Lymphoma of the uvea: an analysis of 3 cases |
title | Mucosal associated Lymphoid Tissue Lymphoma of the uvea: an analysis of 3 cases |
title_full | Mucosal associated Lymphoid Tissue Lymphoma of the uvea: an analysis of 3 cases |
title_fullStr | Mucosal associated Lymphoid Tissue Lymphoma of the uvea: an analysis of 3 cases |
title_full_unstemmed | Mucosal associated Lymphoid Tissue Lymphoma of the uvea: an analysis of 3 cases |
title_short | Mucosal associated Lymphoid Tissue Lymphoma of the uvea: an analysis of 3 cases |
title_sort | mucosal associated lymphoid tissue lymphoma of the uvea: an analysis of 3 cases |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484074/ https://www.ncbi.nlm.nih.gov/pubmed/36123589 http://dx.doi.org/10.1186/s12886-022-02598-2 |
work_keys_str_mv | AT wangzhenyu mucosalassociatedlymphoidtissuelymphomaoftheuveaananalysisof3cases AT liuyueming mucosalassociatedlymphoidtissuelymphomaoftheuveaananalysisof3cases AT mojing mucosalassociatedlymphoidtissuelymphomaoftheuveaananalysisof3cases AT caoxusheng mucosalassociatedlymphoidtissuelymphomaoftheuveaananalysisof3cases AT xuxiaolin mucosalassociatedlymphoidtissuelymphomaoftheuveaananalysisof3cases AT shenlin mucosalassociatedlymphoidtissuelymphomaoftheuveaananalysisof3cases AT wanghong mucosalassociatedlymphoidtissuelymphomaoftheuveaananalysisof3cases AT weiwenbin mucosalassociatedlymphoidtissuelymphomaoftheuveaananalysisof3cases |